Ca2+ sensitizing effects of EMD 53998 after troponin replacement in skinned fibres from porcine atria and ventricles.
Skinned fibres from porcine ventricles exhibited a higher Ca2+ sensitivity (pCa50, i.e. -log10 Ca2+ concentration required for half-maximal activation, for force generation) than atrial fibres. The thiadiazinone derivative EMD 53998 increased Ca2+ sensitivity and Ca2+ efficacy in both preparations. The drug effect depended on the isoform of troponin (Tn). Using the vanadate method TnI and TnC could be partly extracted and replaced by foreign tropin or by the TnI subunit of added foreign troponins. We investigated the relationship between pCa and force development before and after replacement of TnI with foreign troponin (bovine ventricular troponin, cTn, or rabbit skeletal muscle troponin, sTn) in the presence and absence of EMD 53998. Substitution with bovine cTn increased Ca2+ sensitivity to a value characteristic of bovine ventricular skinned fibres (pCa50 = 5.4) and was further increased by EMD 53998. Substitution with sTn also increased Ca2+ sensitivity, but subsequent addition of EMD 53998 caused little further increase in Ca2+ sensitivity. Following extraction of TnI with vanadate, skinned fibres contracted in a Ca(2+)-independent manner and failed to relax at a pCa of 8. Relaxation could be induced, however, by bovine ventricular TnI and rabbit skeletal muscle recombinant TnI. This relaxation could be reversed by EMD 53998 (100 microM). The Ca(2+)-independent force of contracted fibres could also be depressed by a TnI inhibitory peptide, (cTnI 137-148) and, in addition, this effect was antagonized by EMD 53998.(ABSTRACT TRUNCATED AT 250 WORDS)
Barth
Z
Z
Department of Physiology II, University of Heidelberg, Germany.
Strauss
J D
JD
Heyder
S
S
Van Eyk
J
J
Wiesner
R J
RJ
Rüegg
J C
JC
D000818:Animals; D016275:Atrial Function; D002118:Calcium / Q000494:pharmacology*; D002316:Cardiotonic Agents / Q000494:pharmacology*; D002417:Cattle; D006352:Heart Ventricles / Q000737:chemistry; D018482:Muscle, Skeletal / Q000737:chemistry; D009200:Myocardial Contraction / Q000187:drug effects*; D011804:Quinolines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D011994:Recombinant Proteins / Q000494:pharmacology; D013552:Swine; D013829:Thiadiazines / Q000494:pharmacology*; D014336:Troponin / Q000494:pharmacology* / Q000502:physiology*; D019209:Troponin C; D019210:Troponin I; D014638:Vanadates / Q000494:pharmacology; D016276:Ventricular Function
D002316:Cardiotonic Agents; D011804:Quinolines; D011994:Recombinant Proteins; D013829:Thiadiazines; D014336:Troponin; D019209:Troponin C; D019210:Troponin I; C070609:EMD 53998; D014638:Vanadates; D002118:Calcium